2026-10-12T21:27:35Z https://www.scidb.cn/oai

10.57760/sciencedb.35800 2026-05-08T14:42:20Z

2026-05-08 Raw untargeted metabolomics data of Mallard Bursa of Fabricius doi:10.57760/sciencedb.35800 en The study randomly selected Bursa of Fabricius tissues of Mallards from groups C0 (control group), C1 (1 mg/L), C2 (10 mg/L), and C3 (100 mg/L) after 6 weeks of PE-MPs treatment for untargeted metabolomics analysis. Six biological replicates were used for each treatment group. The sample IDs were as follows: C0 group (C0_16_D, C0_17_D, C0_18_D, C0_19_D, C0_20_D, C0_21_D); C1 group (C1_16_D, C1_17_D, C1_18_D, C1_19_D, C1_20_D, C1_21_D); C2 group (C2_16_D, C2_17_D, C2_18_D, C2_19_D, C2_20_D, C2_21_D); C3 group (C3_16_D, C3_17_D, C3_18_D, C3_19_D, C3_20_D, C3_21_D). In the raw data files, for negative ion mode NEG: C0_16_D (HFX14_CN1_FZTM250179581-1A), C0_17_D (HFX14_CN1_FZTM250179582-1A), C0_18_D (HFX14_CN1_FZTM250179583-1A), C0_19_D (HFX14_CN1_FZTM250179584-1A), C0_20_D (HFX14_CN1_FZTM250179585-1A), C0_21_D (HFX14_CN1_FZTM250179586-1A); C1_16_D (HFX14_CN2_FZTM250179587-1A), C1_17_D (HFX14_CN2_FZTM250179588-1A), C1_18_D (HFX14_CN2_FZTM250179589-1A), C1_19_D (HFX14_CN2_FZTM250179590-1A), C1_20_D (HFX14_CN2_FZTM250179591-1A), C1_21_D (HFX14_CN2_FZTM250179592-1A); C2_16_D (HFX14_CN3_FZTM250179593-1A), C2_17_D (HFX14_CN3_FZTM250179594-1A), C2_18_D (HFX14_CN3_FZTM250179595-1A), C2_19_D (HFX14_CN3_FZTM250179596-1A), C2_20_D (HFX14_CN3_FZTM250179597-1A), C2_21_D (HFX14_CN3_FZTM250179598-1A); C3_16_D (HFX14_CN4_FZTM250179599-1A), C3_17_D (HFX14_CN4_FZTM250179600-1A), C3_18_D (HFX14_CN4_FZTM250179601-1A), C3_19_D (HFX14_CN4_FZTM250179602-1A), C3_20_D (HFX14_CN4_FZTM250179603-1A), C3_21_D (HFX14_CN4_FZTM250179604-1A). In positive ion mode POS: C0_16_D (HFX14_CP1_FZTM250179581-1A), C0_17_D (HFX14_CP1_FZTM250179582-1A), C0_18_D (HFX14_CP1_FZTM250179583-1A), C0_19_D (HFX14_CP1_FZTM250179584-1A), C0_20_D (HFX14_CP1_FZTM250179585-1A), C0_21_D (HFX14_CP1_FZTM250179586-1A); C1_16_D (HFX14_CP2_FZTM250179587-1A), C1_17_D (HFX14_CP2_FZTM250179588-1A), C1_18_D (HFX14_CP2_FZTM250179589-1A), C1_19_D (HFX14_CP2_FZTM250179590-1A), C1_20_D (HFX14_CP2_FZTM250179591-1A), C1_21_D (HFX14_CP2_FZTM250179592-1A); C2_16_D (HFX14_CP3_FZTM250179593-1A), C2_17_D (HFX14_CP3_FZTM250179594-1A), C2_18_D (HFX14_CP3_FZTM250179595-1A), C2_19_D (HFX14_CP3_FZTM250179596-1A), C2_20_D (HFX14_CP3_FZTM250179597-1A), C2_21_D (HFX14_CP3_FZTM250179598-1A); C3_16_D (HFX14_CP4_FZTM250179599-1A), C3_17_D (HFX14_CP4_FZTM250179600-1A), C3_18_D (HFX14_CP4_FZTM250179601-1A), C3_19_D (HFX14_CP4_FZTM250179602-1A), C3_20_D (HFX14_CP4_FZTM250179603-1A), C3_21_D (HFX14_CP4_FZTM250179604-1A). After tissue metabolites were extracted, equal volumes of each experimental sample were mixed as quality control samples. A 53% methanol aqueous solution was used instead of the experimental sample (QC) and processed in the same way as the experimental samples to serve as blank samples (blank). Detection and analysis were performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS), followed by data preprocessing, peak annotation, and statistical analysis. Non-targeted metabolomics analysis was performed on a Thermo Scientific Q Exactive™ HF-X Hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Untargeted metabolomics; Bursa of Fabricius; PE-MPs; LC-MS/MS; Mallards shouhai yuan Zhanghonghai EMBARGO https://creativecommons.org/licenses/by-nc-sa/4.0/ dataset Science Data Bank